AGP Picks
View all

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on June 1, 2026

AFRICANLICIOUS LAUNCHES GLOBAL MARKETPLACE TURNING AFRICAN FOOD, CULTURE AND TALENT INTO OPPORTUNITY
EIN Presswire Announces June Special on Press Release Distribution Packages
XS.com Conquista o Prêmio de “Melhor Programa de IB” na Wealth Expo Colombia 2026
Orano Increases Ownership in Cigar Lake Mine in Canada
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones
LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657
Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders
K2 Group releases its 2025 Sustainability Report
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
DEEP SEA MINERALS CORP. ACHIEVES SUBSTANTIAL COMPLIANCE DETERMINATION FROM NOAA UNDER DSHMRA FOR SEABED MINERAL CONCESSIONS

Share this page:

Sign up for:

Africa News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.